Global blood bags market is forecast to grow at a CAGR of over 9% during 2023-2027 owing to rising incidences of blood-related disorders and increasing number of road accidents that require immediate blood transfusion. Additionally, government initiatives to boost healthcare sector, rising number of hospitals, blood banks and other healthcare centers are driving the growth of blood bags market across the globe. Growing awareness over blood donation among citizens is also propelling the demand for blood bags around the globe.
Blood bags are used for the storage, collection, transfusion, and transportation of blood along with the blood components such as RBC, WBC, and blood platelets. Additionally, they also prevent the blood from coagulation and contamination.
Increase in Demand for Blood Transfusion
An increase in the number of patients with sickle cell anaemia, chronic diseases and blood cancers is boosting demand for blood transfusions. The patients suffering from sickle cell anaemia require to go through blood transfusion throughout their lives. As per WHO, in low-income countries, about 50% of the transfusions are done among the children that fall under the age group of 5 years, whereas, in high-income countries, a maximum amount of transfusion is done for the patients falling in the age group of 65 years or above. Furthermore, with the increase in the number of accidents, massive blood transfusions are also required if the patient has suffered major blood loss or any kind of shock. Increase in blood transfusions will require more donations, which will further require more blood bags for collection and storage of the blood.
Growing Number of Blood Banks and Hospitals
Over the years, there has been an increase in the number of blood banks and hospitals, which has further increased the number of transfusions. More and more blood banks and hospitals have been established to aid people suffering from various chronic diseases, which is facilitating rising number of transfusions in these healthcare centers.
Click here to download the sample
Market Segmentation
The global blood bags market is segmented based on
Among all the regions, Asia-Pacific is expected to dominate the blood bags market in the coming years because of the increase in demand towards the sterility aspects, storage, transfusion and transportation of blood and its components. The region is also undergoing rapid developments, especially in healthcare sector and construction of hospitals & health clinics is also surging, which is anticipated to positively impact the market through 2027. COVID-19 outbreak is having an adverse impact on the blood bag market as a rising number of people are becoming increasingly concerned about donating blood due to transmission of the virus.
Major players operating in the global blood bags market include Terumo Corporation, Maco Pharma International GmbH, Fresenius SE & Co KGaA, Grifols S.A., Neomedic Limited, Teleflex Incorporated, Qingdao Sinoland International Trade Co., HLL Lifecare Limited, JMS Co.Ltd., Demophorius Healthcare Ltd, Kawasumi Laboratories, Inc., Poly Medicure Ltd., AdvaCare Pharma, Troge Medical GmbH, Haemonetics Corporation and others. The companies are focusing on bringing innovative and environment friendly products to hold their dominance in the blood bags market across the globe.
Attribute | Details |
Base Year | 2021 |
Historical Data | 2017 – 2020 |
Estimated Year | 2022 |
Forecast Period | 2023 – 2027 |
Quantitative Units | Revenue in USD Million, Volume in Units and CAGR for 2017-2021 and 2022E-2027F | |
Report coverage | Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends | |
Segments covered | · Product · Type · Volume · Material · End User |
Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
Country scope | United States, Mexico, Canada, China, India, Japan, South Korea, Australia; Singapore, Germany, France, United Kingdom, Spain, Italy, Russia, South Africa, UAE, Saudi Arabia, Brazil, Argentina, Colombia |
Key companies profiled | Terumo Corporation, Maco Pharma International GmbH, Fresenius SE & Co KGaA, Grifols S.A., Neomedic Limited, Teleflex Incorporated, Qingdao Sinoland International Trade Co., HLL Lifecare Limited, JMS Co.Ltd., Demophorius Healthcare Ltd, Kawasumi Laboratories, Inc., Poly Medicure Ltd., AdvaCare Pharma, Troge Medical GmbH, Haemonetics Corporation. |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |